Insider · CIK 0001705295
Ford David A
Reports to the SEC for 2 companies · BRISBANE, CA
Transactions
50
Companies
2
Filings
7
CIK
0001705295
Forms 4 and 5
Insider transactions
| Date | Company | Value |
|---|---|---|
| 2025-03-05 | PRTAPROTHENA CORP PUBLIC LTD CO · Stock Option (Right to Buy)A Award | — |
| 2024-03-01 | PRTAPROTHENA CORP PUBLIC LTD CO · Stock Option (Right to Buy)A Award | — |
| 2023-11-08 | INTERCEPT PHARMACEUTICALS, INC.D Disposition to Issuer | −$407K |
| 2023-11-08 | INTERCEPT PHARMACEUTICALS, INC.Option to Purchase Common StockD Disposition to Issuer | — |
| 2023-11-08 | INTERCEPT PHARMACEUTICALS, INC.Option to Purchase Common StockD Disposition to Issuer | — |
| 2023-11-08 | INTERCEPT PHARMACEUTICALS, INC.Option to Purchase Common StockD Disposition to Issuer | — |
| 2023-11-08 | INTERCEPT PHARMACEUTICALS, INC.Option to Purchase Common StockD Disposition to Issuer | — |
| 2023-11-08 | INTERCEPT PHARMACEUTICALS, INC.Option to Purchase Common StockD Disposition to Issuer | — |
| 2023-11-08 | INTERCEPT PHARMACEUTICALS, INC.Option to Purchase Common StockD Disposition to Issuer | — |
| 2023-11-08 | INTERCEPT PHARMACEUTICALS, INC.U Disposition from Tender | −$286K |
| 2023-11-08 | INTERCEPT PHARMACEUTICALS, INC.Option to Purchase Common StockD Disposition to Issuer | — |
| 2023-11-08 | INTERCEPT PHARMACEUTICALS, INC.Option to Purchase Common StockD Disposition to Issuer | — |
| 2023-11-08 | INTERCEPT PHARMACEUTICALS, INC.Option to Purchase Common StockD Disposition to Issuer | — |
| 2023-11-08 | INTERCEPT PHARMACEUTICALS, INC.Option to Purchase Common StockD Disposition to Issuer | — |
| 2023-01-27 | INTERCEPT PHARMACEUTICALS, INC.Option to Purchase Common StockA Award | — |
| 2023-01-27 | INTERCEPT PHARMACEUTICALS, INC.A Award | — |
| 2022-12-31 | INTERCEPT PHARMACEUTICALS, INC.F Tax Payment | −$22K |
| 2022-01-27 | INTERCEPT PHARMACEUTICALS, INC.Option to Purchase Common StockA Award | — |
| 2022-01-27 | INTERCEPT PHARMACEUTICALS, INC.A Award | — |
| 2022-01-01 | INTERCEPT PHARMACEUTICALS, INC.F Tax Payment | −$1,726.74 |
| 2021-12-31 | INTERCEPT PHARMACEUTICALS, INC.F Tax Payment | −$26.2K |
| 2021-10-01 | INTERCEPT PHARMACEUTICALS, INC.F Tax Payment | −$1,400.24 |
| 2021-07-01 | INTERCEPT PHARMACEUTICALS, INC.F Tax Payment | −$1,883.24 |
| 2021-05-08 | INTERCEPT PHARMACEUTICALS, INC.F Tax Payment | −$2,195.2 |
| 2021-04-01 | INTERCEPT PHARMACEUTICALS, INC.F Tax Payment | −$2,233.76 |
| 2021-02-08 | INTERCEPT PHARMACEUTICALS, INC.F Tax Payment | −$5,333.92 |
| 2021-01-22 | INTERCEPT PHARMACEUTICALS, INC.Option to Purchase Common StockA Award | — |
| 2021-01-22 | INTERCEPT PHARMACEUTICALS, INC.A Award | — |
| 2021-01-01 | INTERCEPT PHARMACEUTICALS, INC.F Tax Payment | −$2,618.2 |
| 2020-12-31 | INTERCEPT PHARMACEUTICALS, INC.F Tax Payment | −$15.5K |
| 2020-11-08 | INTERCEPT PHARMACEUTICALS, INC.F Tax Payment | −$3,603.2 |
| 2020-10-01 | INTERCEPT PHARMACEUTICALS, INC.F Tax Payment | −$3,871.36 |
| 2020-08-08 | INTERCEPT PHARMACEUTICALS, INC.F Tax Payment | −$6,240 |
| 2020-07-01 | INTERCEPT PHARMACEUTICALS, INC.F Tax Payment | −$4,279.84 |
| 2020-05-08 | INTERCEPT PHARMACEUTICALS, INC.F Tax Payment | −$11.2K |
| 2020-04-09 | INTERCEPT PHARMACEUTICALS, INC.S Sale | −$4,060 |
| 2020-04-01 | INTERCEPT PHARMACEUTICALS, INC.F Tax Payment | −$5,372.8 |
| 2020-02-08 | INTERCEPT PHARMACEUTICALS, INC.F Tax Payment | −$14.1K |
| 2020-01-23 | INTERCEPT PHARMACEUTICALS, INC.A Award | — |
| 2020-01-23 | INTERCEPT PHARMACEUTICALS, INC.Option to Purchase Common StockA Award | — |
| 2020-01-01 | INTERCEPT PHARMACEUTICALS, INC.F Tax Payment | −$13.1K |
| 2019-12-31 | INTERCEPT PHARMACEUTICALS, INC.F Tax Payment | −$40K |
| 2019-11-08 | INTERCEPT PHARMACEUTICALS, INC.F Tax Payment | −$10.6K |
| 2019-10-23 | INTERCEPT PHARMACEUTICALS, INC.S Sale | −$4,060 |
| 2019-10-01 | INTERCEPT PHARMACEUTICALS, INC.F Tax Payment | −$6,060.04 |
| 2019-09-16 | INTERCEPT PHARMACEUTICALS, INC.S Sale | −$56K |
| 2019-08-08 | INTERCEPT PHARMACEUTICALS, INC.F Tax Payment | −$8,454.4 |
| 2019-07-01 | INTERCEPT PHARMACEUTICALS, INC.F Tax Payment | −$7,283.64 |
| 2019-05-08 | INTERCEPT PHARMACEUTICALS, INC.F Tax Payment | −$11.2K |
| 2019-04-01 | INTERCEPT PHARMACEUTICALS, INC.F Tax Payment | −$10.3K |
Recent filings
- 4Ford David A0000905148-25-000881SEC(opens sec.gov)
- 4Ford David A0000905148-24-000889SEC(opens sec.gov)
- 4Ford David A0001104659-23-117100SEC(opens sec.gov)
- 4Ford David A0001104659-23-008584SEC(opens sec.gov)
- 4Ford David A0001104659-23-000330SEC(opens sec.gov)
- 4Ford David A0001104659-22-009558SEC(opens sec.gov)
- 4Ford David A0001104659-22-000923SEC(opens sec.gov)
Companies
Address
C/O PROTHENA BIOSCIENCES INC 1800 SIERRA POINT PARKWAY
BRISBANE, CA, 94005